The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,685,371 in first-year total cost, median $242,058.
Most frequent study sections
- Special Emphasis Panel[ZAI1 LG-M (M2)]1
- Special Emphasis Panel[ZAI1 MFH-M (S1)]1
- Special Emphasis Panel[ZAI1 SA-M (J1)]1
- Special Emphasis Panel[ZAI1 SAS-M (M1)]1
- Special Emphasis Panel[ZAI1 TCB-I (M1)]1
Most frequent institutions
- BENAROYA RESEARCH INST AT VIRGINIA MASON1
- GEORGE WASHINGTON UNIVERSITY1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES1
- SURGICAL INFECTION SOCIETY FOUNDATION FOR EDUCATION AND RESEARCH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Evaluating the role of high-dose influenza vaccine in people with Down syndrome under age 651R34AI184065-01A1 | KHOR, BERNARDSPEAKE, CATE | BENAROYA RESEARCH INST AT VIRGINIA MASON, WA | $286,793 | ZAI1 |
| 2025 | Oral N-Acetylglucosamine as Anti-Neuroinflammatory Add-on therapy for Multiple Sclerosis (NANA-MS)1R34AI184342-01A1 | DEMETRIOU, MICHAELSY, MICHAEL YU | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $263,892 | ZAI1 |
| 2025 | AAV-delivery of broadly neutralizing antibodies to augment ART-free control of HIV-1 in children1R34AI195134-01 | LUZURIAGA, KATHERINE F. | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $251,250 | ZAI1 |
| 2025 | Planning for Na-GST-1 Hookworm Vaccine Phase 2 CHIM Efficacy Trial1R34AI189333-01 | DIEMERT, DAVID JOSEPH | GEORGE WASHINGTON UNIVERSITY, DC | $242,058 | ZAI1 |
| 2025 | Novel strategies for treatment of Mycobacterium abscessus pulmonary disease1R34AI186857-01 | DORMAN, SUSAN EWINTHROP, KEVIN LORING | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $240,878 | ZAI1 |
| 2025 | An adaptive, randomized controlled trial to treat BK polyomavirus infections (BKPyV) in pediatric kidney transplant recipients1R34AI184112-01A1 | DHARNIDHARKA, VIKAS R. | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $235,500 | ZAI1 |
| 2024 | Biomarker-Guided Antimicrobial optimization to reduce complications from intra-abdominal infections1R34AI178842-01A1 | SAWYER, ROBERT G | SURGICAL INFECTION SOCIETY FOUNDATION FOR EDUCATION AND RESEARCH, NY | $165,000 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.